| | 796967-16-3 Basic information More.. |
| Product Name: | Linifanib (ABT-869) | | Synonyms: | 1-(4-(3-amino-1H-indazol-4-yl)phenyl)-3-(2-fluoro-5-methylphenyl)urea;Linifanib;N-[4-(3-Amino-1H-indazol-4-yl)phenyl]-N'-(2-fluoro-5-methylphenyl)urea;N-(4-(3-Amino-1H-indazol-4-yl)phenyl)-N1-(2-fluoro-5-methylphenyl)urea;Urea, N-(4-(3-amino-1H-indazol-4-yl)phenyl)-N'-(2-fluoro-5-methylphenyl)-;ABT-869 5.2G;AL-39324;RG3635 | | CAS: | 796967-16-3 | | MF: | C21H18FN5O | | MW: | 375.4 | | EINECS: | | | Mol File: | 796967-16-3.mol |  |
Use
Linifanib (ABT-869) is a novel, potent ATP-competitive RTK inhibitor for KDR, CSF-1R, Flt-1, Flt-3 and PDGFRβ with IC50 of 4 nM, 3 nM, 3 nM, 3 nM, and 66 nM respectively.
- Linifanib (ABT-869)
-
- US $1.00 / KG
- 2020-01-03
- CAS:796967-16-3
- Min. Order: 1KG
- Purity: 99%
- Supply Ability: 200kg
|
|
796967-16-3
Recommend Suppliers |
|